- Home
- GRFS vs FRPT Comparison
GRFS vs FRPT Comparison
Compare GRFS & FRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFS
- FRPT
- Stock Information
- Founded
- GRFS 1940
- FRPT 2004
- Country
- GRFS Spain
- FRPT United States
- Employees
- GRFS N/A
- FRPT N/A
- Industry
- GRFS Biotechnology: Pharmaceutical Preparations
- FRPT Packaged Foods
- Sector
- GRFS Health Care
- FRPT Consumer Staples
- Exchange
- GRFS Nasdaq
- FRPT Nasdaq
- Market Cap
- GRFS 5.5B
- FRPT 6.5B
- IPO Year
- GRFS 2006
- FRPT 2014
- Fundamental
- Price
- GRFS $7.27
- FRPT $156.96
- Analyst Decision
- GRFS Strong Sell
- FRPT Strong Buy
- Analyst Count
- GRFS 1
- FRPT 15
- Target Price
- GRFS N/A
- FRPT $165.60
- AVG Volume (30 Days)
- GRFS 704.7K
- FRPT 497.7K
- Earning Date
- GRFS 01-01-0001
- FRPT 02-24-2025
- Dividend Yield
- GRFS N/A
- FRPT N/A
- EPS Growth
- GRFS N/A
- FRPT N/A
- EPS
- GRFS 0.27
- FRPT 0.88
- Revenue
- GRFS $7,814,096,584.00
- FRPT $927,890,000.00
- Revenue This Year
- GRFS $9.31
- FRPT $29.88
- Revenue Next Year
- GRFS $7.44
- FRPT $24.59
- P/E Ratio
- GRFS $31.76
- FRPT $177.43
- Revenue Growth
- GRFS 7.21
- FRPT 29.36
- 52 Week Low
- GRFS $5.30
- FRPT $84.02
- 52 Week High
- GRFS $9.96
- FRPT $160.91
- Technical
- Relative Strength Index (RSI)
- GRFS 43.85
- FRPT 67.51
- Support Level
- GRFS $7.00
- FRPT $141.27
- Resistance Level
- GRFS $7.53
- FRPT $156.19
- Average True Range (ATR)
- GRFS 0.24
- FRPT 4.49
- MACD
- GRFS -0.01
- FRPT 1.31
- Stochastic Oscillator
- GRFS 27.00
- FRPT 93.73
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.
About FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. The former two store types accounted for 89% of 2023 sales, with grocery stores representing the primary driver of footprint growth. Freshpet primarily targets dogs (92% of sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 96% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.